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Abstract
Following a large outbreak of community-acquired psittacosis in 2002 in residents of the Blue Mountains, New South Wales, Australia, we
reviewed new cases in this area over a 7-year period from 2003 to 2009. Using the 2010 criteria from the Centers for Disease Control
National Notifiable Diseases Surveillance System, 85 patients with possible psittacosis were identified, of which 48 were identified as
definite or probable infection. Clinical features of these cases are summarized. In addition to Chlamydia-specific serology, specimens, where
available, underwent nucleic acid testing for chlamydial DNA using real-time PCR. Chlamydophila psittaci DNA was detected in samples from
23 patients. Four of 18 specimens were culture positive. This is the first description of endemic psittacosis, and is characterized in this
location by community-acquired psittacosis resulting from inadvertent exposure to birds. The disease is likely to be under-diagnosed, and
may often be mistaken for gastroenteritis or meningitis given the frequency of non-respiratory symptoms, particularly without a history of
contact with birds. Clinical characteristics of endemic and outbreak-associated cases were similar. The nature of exposure, risk factors and
reasons for the occurrence of outbreaks of psittacosis require further investigation.
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Introduction
Among members of the chlamydiaceae family, there is now a
single genus (Chlamydia) that includes three major human
pathogens: Chlamydophila pneumoniae, C. psittaci and C. tracho-
matatis [1]. Chlamydophila psittaci is the agent of a multisystem
disease called ‘psittacosis’ [2]. This zoonotic infection most
commonly occurs in people with a history of exposure to birds
in either the setting of occupational or companion animal
exposure [3, 4]. It causes community-acquired pneumonia with
a frequency of less than 2% [5, 6]. The features of psittacosis
were extensively reviewed prior to the identification of C.
pneumoniae as an alternative diagnosis of chlamydial pneumonia
[7, 8]. It is recognized now that human respiratory infection
can be caused by both C. pneumoniae and C. psittaci.
Micro-immunofluorescence (MIF) serology together with
rapid ELISA screening has for many years been the mainstay of
diagnosis of psittacosis and is reported to be more specific
than complement fixation testing (CFT) [9]. Initial ELISA
testing for Chlamydia-specific IgG and IgA may be used to
screen specimens prior to the more laborious MIF testing,
which is often reserved for testing acute and convalescent
specimens in parallel. Recently, diagnostic criteria for psitta-
cosis have been published by the USA Centers for Disease
Control (CDC) National Notifiable Disease Surveillance
System (NNDSS), classifying cases as confirmed or probable
according to culture, species-specific nucleic acid testing
(NAT) and serology (http://www.cdc.gov/nndss, under psitta-
cosis).
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The Blue Mountains region is west of Sydney, New South
Wales, Australia, and is a heavily forested area with an altitude
gradient from sea level to 1000 m. The human population
resides close to the major roads and railway lines that traverse
the mountains. Similar numbers of the population live below an
altitude of 360 m (lower mountains) and above this altitude
(upper mountains). Despite the presence of similar bird
species populations in both regions the majority of cases of
psittacosis occur in the upper mountains. The factors respon-
sible for this remain unclear but may pertain to the environ-
mental survival of C. psittaci. The entire Blue Mountains region
abounds in bird life, particularly in psittacine birds, such as the
crimson rosella (Platycercus elegans), the king parrot (Alisterus
scapularis) and the sulphur-crested cockatoo (Cacatua galerita).
In 2002, an outbreak of 59 cases of serologically diagnosed
(and hence probable) community-acquired psittacosis
occurred [10]. Epidemiological risk factors included residence
in the upper mountains, males between the ages of 40 and 60
years, recent sighting of birds and mowing lawns without a
grass-catcher. It was suggested that mowing lawns and other
selected outdoor activities may generate infective aerosols of
bird material and secretions, an explanation also given for an
outbreak of 16 cases in Bright, Victoria, Australia, in 1997 [11].
Both these Australian reports were criticized because they did
not provide conclusive evidence that the infective agent was C.
psittaci. In this study, we describe endemic commu-
nity-acquired psittacosis and summarize the clinical features
of confirmed and probable cases, using the 2010 CDC NNDSS
definitions as the basis for diagnosis.
Methods
The Blue Mountains Local Government Area (BMLGA) was
chosen as the location for this study. Psittacosis is notifiable to
public health authorities in New South Wales, with cases
consistently reported from the BMLGA. Notified cases were
reviewed and classified as confirmed, probable or possible.
Cases were classified as confirmed if the organism was
cultured, or there was a fourfold rise in species-specific
antibody (using MIF). Cases were classified as probable if there
was a positive, species-specific, NAT result (using PCR) or a
single serology result with a MIF titre equal to or greater than
128 (one dilution higher than the manufacturer’s recommen-
dation). Enzyme immunoassay (EIA) seropositivity was used as
the trigger for performing MIF. To avoid low-level seropositive
results, patients with MIF titres of 1:64 or less were regarded
as possible cases only, and were excluded. Patients with only
EIA evidence (cut-off ratio of 2.2) of chlamydial infection
without species-specific confirmation by MIF or PCR were
regarded as possible cases and not analysed further. Absence
of alternative diagnoses and lack of positive species-specific
PCR for other chlamydial species was required for inclusion.
Active surveillance for clinical cases of community-acquired
psittacosis was implemented in 2002. People presenting to the
Blue Mountains Hospital Emergency Department with com-
munity-acquired pneumonia or an unexplained febrile illness
had throat swabs collected for chlamydial PCR and culture, as
well as other specimens for serology and PCR. Chlamydial
PCR was performed using a Corbett real-time platform with
genus-specific [12, 13] and two species-specific primers [14–
16]. More recently, an additional primer sequence based on
the INC A gene was used [17]. PCR tests for C. pneumoniae and
C. trachomatis DNA were performed in parallel, using primers
based on the published species-specific sequences, to exclude
inadvertent species cross-reactions [15, 16].
Limited numbers of specimens were available for culture:
because of the potential laboratory risks, only those specimens
that were PCR-positive were cultured. Specimens were
cultured in a monkey green kidney cell line using two passages
as described [14]. Chlamydial cultures were confirmed using
both the genus-specific direct fluorescence assay Pathfinder
(Biorad, Hercules, CA, USA) and the species-specific PCR.
Initial (acute) serology was performed using an EIA screen
for chlamydial IgG and IgA (Medac, Wedel, Germany). The
manufacturer’s cut-off of 1.0 was raised to 2.2 following an
in-house assessment that the specificity was increased at this
level (data not shown). EIA testing, if positive, was followed by
MIF IgG testing (Savyon, Ashod, Israel). Where acute and
convalescent specimens were available, MIF assays were
performed in parallel in one laboratory. C. pneumoniae and C.
trachomatis MIFs were performed concurrently.
Follow-up public health surveys and reviews of inpatient
medical records were used to determine clinical presentation
and risk factors of cases. Where possible, patients were
interviewed soon after the diagnosis and questioned about
possible risk exposures to birds. Convalescent serology was
requested 6 weeks after symptom onset. Re-presentations to
hospital were recorded.
Results
Between January 2003 and December 2009, 84 cases of
psittacosis in the BMLGA were notified to the regional public
health unit. Twenty-one patients did not meet the diagnostic
criteria of proven or probable psittacosis and were excluded.
Four patients were not available for follow-up. Five patients
who lived outside the BMLGA were excluded. Five patients
had an alternative diagnosis (three with C. trachomatis and one
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each with C. pneumoniae and Legionella pneumophila infection).
One patient had a second episode of possible psittacosis and
this episode was excluded. Forty-eight patients met the
diagnostic criteria and lived in the Blue Mountains. The total
number of all presentations of pneumonia in this period was
1184, giving a crude prevalence of 35/1184 (2.9%).
Of the 48 cases included in this study, 14 were definite (four
culture positive and 10 sero-conversions) and 34 probable (18
diagnosed by serology alone and 16 were PCR-positive and/or
serology positive). In total, there were 23 patients with
positive PCR results (six PCR-positive only, nine PCR-positive
plus serology, four PCR-positive plus sero-conversion, two
PCR-positive plus culture, and two PCR-positive plus culture
plus serology, one sero-conversion).
Eight patients gave a history of direct bird contact (handled
birds or kept birds at home); four, of occupational exposure
(veterinary: n = 3, wildlife rescue: n = 1); and nine patients fed
birds in their garden. No records were available for two
patients. The majority of patients did not have a history of
direct bird contact (n = 29, 60%). Indirect contact with birds
(seeing birds and excreta in the environment) was universal. A
history of lawn-mowing was available for 19 patients with 12/
19 (63%) either mowing lawns or using blower devices in the
month prior to illness.
There was a striking seasonality to the cases with 31/45
(69%) presenting in a 3-month period of March to May. There
were no cases in the warmer months of October to
December.
The demographics of residential area, age and sex were
similar to the 2002 outbreak in the same region [10]. There
was a male predominance and a geographic clustering of cases
in the upper mountains.
Clinical and laboratory features
Clinical details were available in 42 of the 48 cases. Thirty-six
patients were hospitalized, with an average length of hospital-
ization of 4.5 days. Forty-two patients reported general
symptoms (including fever, rigors, myalgia), 28 patients had
respiratory symptoms, 26 patients had neurological symptoms,
and 15 patients had gastrointestinal symptoms (Table 1). Two
patients had a rash; one was an itchy truncal maculopapular
rash, possibly related to antibiotic use. In the second case a
rash on the torso was described as a non-urticarial maculo-
papular rash, which lasted 48 h and resolved spontaneously.
The majority, but not all, patients had evidence of
pneumonia (n = 35, 83%). All patients had a fever or a history
of febrile illness. Their average temperature on presentation
was 38.3°C with a peak fever of 39°C and the mean time to
fever resolution was 2.8 days. Headache was common (52%).
Two patients underwent a lumbar puncture; C. psittaci DNA
was detected by PCR in the cerebro-spinal fluid (CSF) of one
patient. Peripheral blood leucocyte counts were generally
normal (mean 9.4 9 109/L) with a mean neutrophil count of
6.3 9 109/L. Serum sodium was mildly decreased in 16 of the
48 cases (mean 131.7, range 126 to 134 mmol/L). In four
patients renal function was mildly abnormal and returned to
normal with recovery.
Liver function tests (LFTs) on presentation were abnormal
in 24 (60%) of 40 patients tested, with no result available in
nine (19%) patients, and normal in 15 (31%). Seventeen (35%)
patients had LFTs less than twice the upper limit of normal
(ULN), six (12.5%) had tests between 2 and 59 ULN, and one
patient had >59 ULN. The predominant abnormality was
transaminitis (n = 21, 44%). Clinical features and co-morbid-
ities at presentation are summarized in Tables 1 and 2.
Chlamydophila psittaci-specific MIF tests
Thirty-eight (of 48) patients were tested. Ten had fourfold
increases in titre, 26 had a single high titre, one had a falling
titre and one remained negative. Single titre results ranged
from 64 to 1024 with a mode of 128.
TABLE 1. Clinical presentations of patients with proven and
probable psittacosis
Symptom
Total (n = 44),
n (%)
Fever 42 (95)
Cough 25 (57)
Headache 23 (52)
Myalgia 10 (23)
Nausea 8 (18)
Diarrhoea 6 (14)
Rigors 6 (14)
Sputum 5 (11)
Chest pain 5 (11)
Dyspnoea 3 (7)
Abdominal pain 2 (5)
Haemoptysis 1 (2)
TABLE 2. Comorbidities in patients with proven and prob-
able psittacosis
Comorbidity
Total (n = 33),
n (%)
Hypertension 5 (15)
Hyperlipidaemia 4 (12)
Ischaemic heart disease 4 (12)
Cancer (prostate and transitional cell
cancer and squamous cell cancer)
3 (9)
Diabetes 3 (9)
Pneumonia 3 (9)
Mental health problems 2 (6)
Chronic airflow limitation 2 (6)
Thyroid disease 2 (6)
Cardiomyopathy 1 (3)
HIV 1 (3)
Asthma 1 (3)
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Twenty-three patients had at least one specimen positive by C.
psittaci PCR; throat swab in 16 and sputum in three; other
positives included CSF, blood and urine. Eight confirmed and
15 probable cases were PCR positive. Eighteen patients had a
specimen available for culture; four (22%) were culture
positive. All four positive cultures were from throat swabs
collected prior to commencement of antibiotics.
Radiology
Thirty-eight patients presented with an abnormal chest X-ray; in
32 there was evidence of consolidation or opacification
suggestive of pneumonia. One patient had X-ray features
suggestive of left ventricular failure and five had non-specific
changes, such as peri-bronchial thickening. The lower lobes
were involved most frequently (24/38, 63%), followed by the
upper lobes in seven (18%) cases and themiddle or lingular lobes
in 5 (13%). Two patients had bilateral abnormalities. The right
lower lobe was affected most commonly, in 15 (39%) patients.
There were five patients with pleural effusions (four unilateral
and one bilateral). In one patient fibrotic changes were noted in
the upper lobes, probably unrelated to psittacosis.
Treatment and follow-up
Most patients were treated with doxycycline (25 of 44 patients;
56%) or roxithromycin (17 out of 44 patients; 38%). One patient
received no effective antibiotics and recovered and one was
treated successfully with a quinolone. One patient (2%) who
required invasive ventilatory support died of respiratory failure
on day 2 of admission. All other patients made a good recovery
with few complications. Six patients re-presented to the hospital
with respiratory symptoms in the year after their episode of
psittacosis. Two of these patients had chronic lung disease and
four had further infective episodes of respiratory illness. Others
presented with migraine headaches (n = 2), back pain (n = 2),
gastrointestinal problems (n = 2) and prostate, sexual health
problems and cerebellar ataxia (one each).
Discussion
Endemic psittacosis has not been described previously. The
term has been used in two other studies where the disease has
a high prevalence [18, 19] but these did not use strictly defined
diagnostic criteria. We now report that, following a large
outbreak in 2002 in the Blue Mountains region of New South
Wales, Australia [10], psittacosis, as defined by the NNDSS
guidelines, is endemic in this region.
Chlamydophila psittaci has been described as a sporadic cause
of community-acquired pneumonia in up to 2% of cases, with a
frequent corresponding history of bird exposure. Amongst our
population the percentage of all pneumonias due to this
pathogen is 2.9% but periodically rises to 10–15%. The results
presented heremay be an under-representation of the incidence
of the disease in the region, as less severe or sub-clinical cases
managed in the primary care setting are unlikely to be tested and
thus unreported to the public health authorities.
Direct bird contact is identified only in a minority of cases
reported from the area, although environment exposure to
psittacine birds in general is largely unavoidable in the region
due to the significant numbers of resident species. Cases occur
every year and are seasonal (predominantly March to May).
We have proven that these cases are due to C. psittaci by
culture, molecular and serological diagnosis. Hence, in our
region, community-acquired psittacosis is endemic and often
occurs without a history of direct bird contact. Further work
is required to identify other risk factors. The high, endemic
prevalence of psittacosis is presumably due to excessive
environmental contamination with native bird material and
prolonged survival of the organism in the environment.
Additional behavioural and environmental factors, such as
altitude, temperature and lawn-mowing, are worthy of further
study.
Many of the clinical descriptions of psittacosis predate
accurate molecular and serological diagnosis. The two largest
case series were reported before C. pneumoniae was recog-
nized as a separate pathogen [7,8]. Presented here is a large
series of patients with psittacosis, whose clinical presentation
is similar to the previous outbreak in this location. We have
confirmed the multi-system nature of clinical presentations and
with frequent headache, myalgia and gastrointestinal symptoms
as well as the major, previously described, laboratory abnor-
malities of hypernatraemia, abnormal LFTs and normal white
cell count (WCC). Chest X-rays revealed a high frequency of
unilateral and lobar pneumonia. Pre-morbid conditions includ-
ing HIV appeared not to influence outcomes adversely.
In this series, non-respiratory symptoms of headache and
neurological presentation were common, mirroring previous
studies [6,7,19,20]. Moreover, we record a case of psittacosis
with a positive PCR result from CSF. This patient had a high
degree of direct bird exposure but lacked a CSF cellular
response and had normal CSF protein and glucose measure-
ments. To our knowledge a positive PCR result from CSF has
only previously been described on one occasion [21]. Clini-
cians unfamiliar with psittacosis may misdiagnose it as viral
illness, meningitis or gastroenteritis, especially in the absence
of suspicion or history of bird exposure [22].
Limited follow-up of patients through a search of admission
data revealed the need for further admission to hospital with
respiratory symptoms in only six (12%) cases of which two had
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pre-existing lung disease. It should be noted that at least two
patients with possible psittacosis died before a complete set of
diagnostic tests could be performed.
In this cohort of patients all three modalities of diagnosis—
serology, PCR and culture—may be useful. However we advise
against routine culture because of the infectivity of C. psittaci.
The suggested serological NNDSS criteria for diagnosis of
psittacosis are stringent. Our laboratory no longer uses CFT
serology as the use of both ELISA and MIF is more reliable
[23]. By increasing the recommended cut-off of both serolog-
ical tests by at least one dilution above the manufacturer’s
recommendation, we ensured that the patients included in this
study were rigorously selected.
The use of genus- and species-specific PCRs that detect
both major respiratory species (C. psittaci and C. pneumoniae) is
useful and could be included in multiplex approaches to the
diagnosis of community-acquired pneumonia.
In our experience molecular diagnosis for confirmation of C.
psittaci-specific PCR with a second or third primer set using a
different target, as well as using three species real-time PCR in
order to exclude infection with C. pneumoniae or C. trachomatis
has been useful. Additionally, we suggest a diagnosis could be
confirmed if there is both molecular and serological evidence
of infection in the context of an appropriate clinical presen-
tation and the absence of alternate diagnosis.
This study was conducted in the setting of routine clinical
care and many patients did not have the requested follow-up
serology or appropriate and timely specimens at follow-up,
limiting the opportunities to confirm all cases. The retrospec-
tive nature of the symptom and follow-up analysis of patients is
by its nature limited by the available documentation. Due to
the attainment of cases through hospital presentation we may
have excluded mild cases from consideration and underesti-
mated the incidence of disease in this environment.
The incidence of C. pneumoniae infection was low in the
present series. Despite using chlamydial serology, PCR and
culture, we were only able to identify two patients with
infection due to C. pneumoniae during this period, suggesting
this pathogen is rare in this geographical area. This is
consistent with other Australian studies showing low preva-
lence of C. pneumoniae [5, 24–26].
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